SCHEMBL6357823

SCHEMBL6357823

O=C(CCN1CCCC(c2ccccc2)C1)c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.69
KMT2A Q03164 6/20 0.69
LMNA P02545 4/20 0.69
GAA P10253 2/20 0.69
SIGMAR1 Q99720 1/20 0.61
DRD2 P14416 2/20 0.58
DRD1 P21728 1/20 0.58
DRD4 P21917 1/20 0.58
DRD5 P21918 1/20 0.58
DRD3 P35462 1/20 0.58
HTT P42858 2/20 0.56
TAAR1 Q96RJ0 4/20 0.55
MAPT P10636 4/20 0.55
KDM4E B2RXH2 1/20 0.55
HTR1A P08908 1/20 0.54
HSD11B1 P28845 1/20 0.53
GFER P55789 1/20 0.52
TSHR P16473 1/20 0.52
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348925 0.91 ALDH1A1 (0.82) ALDH1A1KMT2ALMNAGAASIGMAR1
SCHEMBL6353997 0.88 ALDH1A1 (0.69) ALDH1A1KMT2ALMNAGAASIGMAR1
SCHEMBL6357372 0.83 DRD4 (0.71) ALDH1A1KMT2ALMNAGAADRD2
SCHEMBL6349352 0.81 DRD4 (0.73) ALDH1A1KMT2ALMNAGAADRD2
SCHEMBL6349350 0.81 DRD4 (0.73) ALDH1A1KMT2ALMNAGAADRD2
SCHEMBL6357751 0.78 DRD4 (0.47) ALDH1A1KMT2ALMNAGAASIGMAR1
Hydrochloric Acid SCHEMBL5954525 0.77 ALDH1A1 (0.72) ALDH1A1KMT2ALMNASIGMAR1DRD2
SCHEMBL17033397 0.77 ALDH1A1 (0.72) ALDH1A1KMT2ALMNASIGMAR1DRD4
SCHEMBL14587419 0.76 SIGMAR1 (1.00) ALDH1A1KMT2ALMNAGAASIGMAR1
Hydrochloric Acid SCHEMBL5954595 0.76 ALDH1A1 (0.71) ALDH1A1KMT2ALMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176727-A1 Oximes and hydrazones that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176727-A1 Oximes and hydrazones that are useful in treating sexual dysfunction CYP19A1, SHBG, CYP17A1 ALDH1A1 199/4885KMT2A 1762/4885LMNA 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.